课题基金 / 基金详情

NCP型BVDV急性感染中BTLA调控CD8+TLs活化、增殖及杀伤功能的机制研究

批准号:
32072896
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
刘宇
依托单位:
学科分类:
兽医传染病学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
刘宇

项目摘要

结项摘要

相似基金

相关文献

中文摘要
牛病毒性腹泻病毒(BVDV)急性感染可导致牛外周血淋巴细胞减少症,引起免疫抑制,其发病机制尚不明确。我们前期研究发现NCP和CP型BVDV依赖PD-1通路抑制了T淋巴细胞(TLs)的增殖,引发凋亡和TLs减少。然而,NCP型BVDV感染中阻断PD-1并未完全恢复CD8+TLs增殖和功能,被感染的CD8+TLs表面B/T淋巴细胞衰减因子(BTLA)高表达,增殖被抑制。推测BTLA协同PD-1负调控了CD8+TLs的活化和增殖。本研究拟结合免疫检查点联合阻断干预策略,利用CFSE荧光标记、抗体阻断和基因沉默等技术,确定NCP型BVDV感染中BTLA表达与CD8+TLs活化和增殖的相关性及其对杀伤功能及病毒复制的影响,揭示BTLA与PD-1分子的协同作用和信号转导通路响应机制。对于探索BVDV感染引起免疫抑制的分子机制有重要意义,为2019新型冠状病毒等引发的淋巴细胞减少症提供新的治疗思路。
英文摘要
Acute infection with bovine viral diarrhea virus (BVDV) can results in peripheral blood lymphopenia and immunosuppression. However, the pathogenesis of lymphopenia and immunosuppression remains unclear. Our previous study found that NCP and CP BVDV inhibited the proliferation of T lymphocytes (TLs) and promoted the apoptosis and reduction of TLs by PD-1 pathway. However, PD-1 blockade during NCP BVDV infection did not fully restore the proliferation and function of CD8+TLs. Meanwhile, B and T lymphocyte attenuator (BTLA) on the infected CD8+TLs was highly expressed and the TLs proliferation was inhibited. We hypothesized that BTLA and PD-1 negatively regulated the activation and proliferation of CD8+TLs. In this study, the correlation between BTLA expression and CD8+TLs activation and proliferation and the effect of BTLA on cytotoxicity and virus replication were determined during by antibody blocking, gene silencing and CFSE fluorescence labeling during NCP BVDV infection. The aim is to reveal the synergistic effect between BTLA and PD-1 and the response mechanism of signal transduction pathway. This study is of great significance for exploring the molecular mechanism of immunosuppression induced by BVDV infection, and provides a new therapeutic approach for lymphopenia induced by SARS-CoV-2 and other viruses.
牛病毒性腹泻病毒(BVDV)急性感染可导致牛外周血淋巴细胞减少症,引起免疫抑制,其发病机制尚不明确。我们前期研究发现NCP和CP型BVDV依赖PD-1通路抑制了T细胞的增殖,引发凋亡和T细胞减少。然而,NCP型BVDV感染中阻断程序性死亡受体-1(PD-1)并未完全恢复CD8+T细胞的增殖和功能,被感染的CD8+T细胞表面B/T淋巴细胞衰减因子(BTLA)高表达,增殖被抑制。推测BTLA协同PD-1负调控了CD8+T细胞的活化、增殖和抗病毒功能。本项目结合免疫检查点分子单抗联合阻断干预策略,分析了BVDV感染中BTLA表达与CD8+T细胞活化和增殖的相关性,研究了BTLA调控CD8+T细胞活化和增殖的分子机制,明确了BTLA与PD-1协同调控CD8+T细胞活化、增殖及抗病毒功能的作用及其机制。结果表明:BVDV感染上调了牛外周血CD8+T细胞BTLA、PD-1及其配体HVEM和PD-L1的mRNA和蛋白表达。BVDV感染中BTLA可通过抑制下游PI3K/Akt/mTOR和ERK通路,负调控CD8+T细胞活化和增殖。在CP型BVDV感染中,与单独阻断BTLA或PD-1相比,联合阻断BTLA与PD-1提高了IFN-γ分泌和p-mTOR表达。然而,在NCP型BVDV感染中协同阻断BTLA和PD-1显著上调了CD8+T细胞增殖、CD25和p-ERK的表达。本研究发现为探索病毒感染引发淋巴细胞减少症和免疫抑制的分子机制,及以免疫检查点分子BTLA和PD-1为靶点的抗BVDV免疫防治新策略提供了科学依据。
国内基金
海外基金